Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

Infection causes disturbances in lipid metabolism that may be mediated by cytokines. Therefore we studied plasma lipids, lipoproteins, triglyceride (TG) metabolism, and serum cytokines in three groups: patients with the acquired immunodeficiency syndrome (AIDS) without active secondary infection, patients with evidence of human immunodeficiency virus infection but without clinical AIDS (HIV+), and controls. Plasma TGs and FFA were increased in AIDS, while plasma cholesterol, high density lipoprotein (HDL) cholesterol, apolipoprotein-A-1 (Apo-A-1), low density lipoprotein (LDL) cholesterol, and Apo-B-100 levels were decreased. Increased TG levels in AIDS were primarily due to increases in very low density lipoprotein of normal composition; in addition, LDL and HDL were TG enriched. In HIV+, TGs and FFA were not increased, but total cholesterol, HDL cholesterol, Apo-A-1, and Apo-B-100 were significantly decreased. Interferon-alpha (IFN alpha) and C-reactive protein levels were increased in AIDS, but tumor necrosis factor and haptoglobin levels were not. There was a significant correlation between plasma TGs and IFN alpha levels (r = 0.477; P less than 0.01), but not between TGs and tumor necrosis factor, C-reactive protein, haptoglobin, or P-24 antigen. In addition, there was no relationship between circulating IFN alpha levels and plasma cholesterol, HDL cholesterol, Apo-A-1, LDL cholesterol, Apo-B-100, or FFA. TG clearance time and postheparin lipase were significantly decreased in AIDS and HIV+. There was a strong correlation between serum IFN alpha levels and TG clearance time in AIDS and HIV+ (r = 0.783; P less than 0.001). In summary, decreases in cholesterol and cholesterol containing lipoproteins (including HDL) in both AIDS and HIV+ precede the appearance of hypertriglyceridemia and are not related to IFN alpha or TG levels. Our data raise the possibility that with development of AIDS, subsequent increases in IFN alpha may contribute to increases in plasma TG levels in part by decreasing the clearance of TG.

[1]  Jack Wang,et al.  Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome , 1991 .

[2]  J. Romijn,et al.  Increased resting energy expenditure in human immunodeficiency virus-infected men. , 1990, Metabolism: clinical and experimental.

[3]  M. Emi,et al.  Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. , 1990, The Journal of clinical investigation.

[4]  M. Serio,et al.  Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats. , 1989, Cancer research.

[5]  J. Cohen,et al.  Chylomicron triglyceride clearance: comparison of three assessment methods. , 1989, The American journal of clinical nutrition.

[6]  J. Wang,et al.  Hypertriglyceridemia in the acquired immunodeficiency syndrome. , 1989, The American journal of medicine.

[7]  M. Taskinen,et al.  Changes in serum lipoprotein pattern induced by acute infections. , 1988, Metabolism: clinical and experimental.

[8]  C. Maury,et al.  Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. , 1988, The American journal of medicine.

[9]  A. Cerami,et al.  Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. , 1988, Surgery.

[10]  M. Grieco,et al.  Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations. , 1988, Journal of acquired immune deficiency syndromes.

[11]  J. Gabrilove,et al.  The acute metabolic effects of tumor necrosis factor administration in humans. , 1987, Archives of surgery.

[12]  M. Mayr,et al.  Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. , 1987, The Journal of clinical investigation.

[13]  E. Borden,et al.  Effects of recombinant interferon-alpha 2 treatment upon lipid concentrations and lipoprotein composition. , 1986, Journal of interferon research.

[14]  W. A. Bradley,et al.  Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients , 1986, The Journal of experimental medicine.

[15]  Y. Kerttula,et al.  Serum lipids in viral and bacterial meningitis. , 1986, Scandinavian journal of infectious diseases.

[16]  C. Alvarez,et al.  Lipids, lipoproteins, and apoproteins in serum during infection. , 1986, Clinical chemistry.

[17]  G. Miller,et al.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. , 1982, Journal of lipid research.

[18]  K. Cantell,et al.  Effect of Interferon on Plasma Lipoproteins and on the Activity of Postheparin Plasma Lipases , 1982, Arteriosclerosis.

[19]  M. Kashyap,et al.  A rapid and simple method for measurement of total protein in very low density lipoproteins by the Lowry assay. , 1980, Journal of lipid research.

[20]  R. Krauss,et al.  Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. , 1974, The Journal of clinical investigation.

[21]  S. Rössner,et al.  Comparison between Fractional Turnover Rate of Endogenous Plasma Triglycerides and of Intralipid® (Intravenous Fat Tolerance Test) in Man * , 1974, European journal of clinical investigation.

[22]  R. Lees,et al.  Effects of an experimental viral infection on plasma lipid and lipoprotein metabolism. , 1972, Metabolism: clinical and experimental.

[23]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[24]  M. Mancini,et al.  Determination of the intravenous fat tolerance test with intralipid by nephelometry. , 1972, Atherosclerosis.

[25]  W. Beisel,et al.  Infection with Diplococcus pneumoniae and Salmonella typhimurium in monkeys: changes in plasma lipids and lipoproteins. , 1972, The Journal of infectious diseases.

[26]  S. Rössner,et al.  Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase activity. , 2009, Acta medica Scandinavica.

[27]  J. Gallin,et al.  Serum lipids in infection. , 1969, The New England journal of medicine.

[28]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.